| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 01/24/2002 | CA2415557A1 Compounds for the treatment of sexual dysfunction |
| 01/24/2002 | CA2415347A1 Adenovirus vectors comprising introns |
| 01/24/2002 | CA2415325A1 Preventing airway mucus production by administration of egf-r antagonists |
| 01/24/2002 | CA2415187A1 Dna vaccines encoding hiv accessory proteins |
| 01/24/2002 | CA2414846A1 Immunological combinations for prophylaxis and therapy of helicobacter pylori infection |
| 01/23/2002 | EP1174523A2 Method for detecting an HBV-derived nucleic acid target sequence |
| 01/23/2002 | EP1174514A1 Recombinant influenza viruses with bicistronic vRNAs coding for two genes in tandem arrangement |
| 01/23/2002 | EP1174506A1 C-terminal Erns peptide and analogues thereof |
| 01/23/2002 | EP1174505A1 (Poly)peptides for the preparation of vaccines against Bordetella pertussis and/or Bordetella parapertussis, vaccines based upon such (poly)peptides, and antibodies against such peptides |
| 01/23/2002 | EP1174441A2 Antibodies and fv fragment recognizing antigen ior c2 |
| 01/23/2002 | EP1174148A1 Parenteral medicinal composition containing humanized monoclonal antibody fragment and method for stabilizing the same |
| 01/23/2002 | EP1173765A1 Diagnostic and therapeutic use of antibodies against the urokinase receptor |
| 01/23/2002 | EP1173600A2 Cationic peg-lipids and methods of use |
| 01/23/2002 | EP1173598A1 A herpes simplex virus type 1 (hsv-1)-derived vector for selectively inhibiting malignant cells and methods for its use to treat cancers and to express desired traits in malignant and non-malignant mammalian cells |
| 01/23/2002 | EP1173587A1 Dsp-10 dual-specificity map kinase phosphatase |
| 01/23/2002 | EP1173586A1 Dsp-8 dual-specificity map kinase phosphatase |
| 01/23/2002 | EP1173577A2 Prevention, diagnosis and treatment of lyme disease |
| 01/23/2002 | EP1173573A1 Method for down-regulating il5 activity |
| 01/23/2002 | EP1173571A2 Human ion channel proteins |
| 01/23/2002 | EP1173564A1 Use of a recombinant defective adenovirus comprising a nucleic acid encoding an angiogenic factor for treating pulmonary hypertension |
| 01/23/2002 | EP1173563A1 Compositions and methods for the treatment of tumour |
| 01/23/2002 | EP1173560A1 Collection of prokaryotic dna for two hybrid systems helicobacter pylori protein-protein interactions and application thereof |
| 01/23/2002 | EP1173485A1 Human antibodies to staphylococcus aureus |
| 01/23/2002 | EP1173484A1 Treatment of fibrosis by antagonism of il-13 and il-13 receptor chains |
| 01/23/2002 | EP1173481A1 Inactivated cytokines for immunisation |
| 01/23/2002 | EP1173479A1 49 human secreted proteins |
| 01/23/2002 | EP1173478A1 49 human secreted proteins |
| 01/23/2002 | EP1173477A1 49 human secreted proteins |
| 01/23/2002 | EP1173466A1 Method of inhibiting leukocyte adhesion to fibrinogen |
| 01/23/2002 | EP1173456A1 Secreted proteins and nucleic acids encoding them |
| 01/23/2002 | EP1173414A1 N-protected amines and their use as prodrugs |
| 01/23/2002 | EP1173204A1 Mutant human cd80 and compositions for and methods of making and using the same |
| 01/23/2002 | EP1173202A1 Method for inhibiting cell functioning for use in anti-inflammatory and anti-tumour therapies |
| 01/23/2002 | EP1173201A1 Method for the treatment of fibrosis using an antagonist of the integrin alpha-4 subunit |
| 01/23/2002 | EP1173200A1 Composition for neuronal regeneration comprising myelin-specific antibodies and complement proteins |
| 01/23/2002 | EP1173199A1 RAS ONCOGEN p21 PEPTIDE VACCINES |
| 01/23/2002 | EP0704056B9 Leukocyte adhesion assay |
| 01/23/2002 | EP0700445B1 Stress proteins and uses therefor |
| 01/23/2002 | EP0658118B1 Vaccines against group c neisseria meningitidis |
| 01/23/2002 | CN1332803A Streptococcus antigens |
| 01/23/2002 | CN1332799A Cancer cell vaccine |
| 01/23/2002 | CN1332750A Modified treponema pallidum outer membrane protein, its immunoassay use and immunoassay kit |
| 01/23/2002 | CN1332749A HBV core antigen particles with multiple immunogenic components attached via peptide ligands |
| 01/23/2002 | CN1332637A Preparations containing virus-like particles as immunopotentiators administered through mucosa |
| 01/23/2002 | CN1332633A LAK activity potentiator orginating in shiitake mushroom hyphae extract and LAK activty potentiating preparations containing the same |
| 01/23/2002 | CN1332631A Composition and method for increasing weight gain and feed efficiency |
| 01/23/2002 | CN1332251A Production process of infections chicken cloacal bursa virus resisting monoclonal antibody |
| 01/23/2002 | CN1332015A Freeze dried dyad live hepatitis A and parotitis vaccine |
| 01/23/2002 | CN1332014A Solid fermentation process of producing waxy microecological bacillus prepn |
| 01/23/2002 | CN1078250C Reshaped monoclonal antibodies against immunoglobulin isotype |
| 01/22/2002 | USRE37525 Concurrent administration of acetylsalicylic acid, corticosteroid, indomethacin, or ibuprofen antiinflammatory agent and human immunoglobulin g to treat bronchiolitis caused by respiratory syncytial or parainfluenza virus |
| 01/22/2002 | US6340981 Method and apparatus for stroke substitution |
| 01/22/2002 | US6340743 Antibody ligands for specific binding to stalk of polymeric immunoglobulin receptor of cell with proviso that ligand does not bind to secretory component of receptor |
| 01/22/2002 | US6340673 Administering at or near a site of a tumor of tumorigenic disease a herpes simplex virus vector lacking an expressible .gamma..sub.1 34.5 gene, whereby the growth of tumor is suppressed |
| 01/22/2002 | US6340577 Protein fragments for use in protein targeting |
| 01/22/2002 | US6340480 Natural composition for the treatment of circulatory conditions |
| 01/22/2002 | US6340464 For the vaccination of domestic animals |
| 01/22/2002 | US6340462 For inducing immunological response in a vertebrate to pathogen by inoculating with synthetic recombinant avipox virus modified by presence, in non-essential region of avipox genome, of dna from any source which encodes for antigen |
| 01/22/2002 | US6340461 For immunotherapy |
| 01/22/2002 | US6340460 Therapeutic suppression of specific immune response by administration of oligomeric forms of antigen of controlled chemistry |
| 01/22/2002 | US6340459 Administering to agent capable of inhibiting interaction between cd40 ligand and the cells to inhibit activation of the cells in therapy of reperfusion injury, in an non-transplant recipient |
| 01/22/2002 | CA2259962C Therapeutic applications of t-bam (cd40l) technology to treat diseases involving smooth muscle cells |
| 01/22/2002 | CA2192424C Novel paclitaxel prodrugs, method for preparation as well as their use in selective chemotherapy |
| 01/22/2002 | CA2149333C Eck receptor ligands |
| 01/22/2002 | CA2115564C Escherichia coli o-polysaccharide-protein conjugate vaccine |
| 01/22/2002 | CA2050304C Pharmaceutical composition useful in preventing or treating tumors induced by papillomaruses |
| 01/22/2002 | CA2038398C Dna encoding a growth factor specific for epithelial cells |
| 01/22/2002 | CA1341334C Synthetic peptides from streptococcal m protein and vaccines prepared therefrom |
| 01/18/2002 | CA2349743A1 Diagnostic assay |
| 01/17/2002 | WO2002005146A2 Method for disigning protein libraries with altered immunogenicity |
| 01/17/2002 | WO2002004953A2 Novel tumor antigen useful in diagnosis and therapy of bladder, ovary, lung and kidney cancers |
| 01/17/2002 | WO2002004952A2 Diagnostic and therapeutic methods based on the l1 adhesion molecule for ovarian and endometrial tumors |
| 01/17/2002 | WO2002004646A1 Expression system |
| 01/17/2002 | WO2002004636A1 NOVEL α-CATENIN EXPRESSED IN HEART AND TESTIS |
| 01/17/2002 | WO2002004608A2 Regulation of human oligopeptidase a-like enzyme |
| 01/17/2002 | WO2002004607A1 Human myeloma cell line |
| 01/17/2002 | WO2002004603A2 Method for the modification of biological cells |
| 01/17/2002 | WO2002004602A1 Transformed yeast presenting protein a on the cell surface layer |
| 01/17/2002 | WO2002004599A2 Placental protein having multiple egf-like domains |
| 01/17/2002 | WO2002004522A2 Bifunctional molecules and vectors complexed therewith for targeted gene delivery |
| 01/17/2002 | WO2002004520A2 Transporters and ion channels |
| 01/17/2002 | WO2002004514A2 Compositions and methods for the therapy and diagnosis of lung cancer |
| 01/17/2002 | WO2002004497A2 Multiple antigenic peptides immunogenic against streptococcus pneumoniae |
| 01/17/2002 | WO2002004496A2 Fimh adhesin proteins and methods of use |
| 01/17/2002 | WO2002004495A2 Streptococcus pyogenes antigen |
| 01/17/2002 | WO2002004494A2 Process for the selection of hiv-1 subtype c isolates, selected hiv-1 subtype isolates, their genes and modifications and derivatives thereof |
| 01/17/2002 | WO2002004493A2 Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof |
| 01/17/2002 | WO2002004485A1 Haemagglutinin antigen |
| 01/17/2002 | WO2002004021A1 Treatment of b cell malignancies using combination of b cell depleting antibody and immune modulating antibody related applications |
| 01/17/2002 | WO2002004019A2 Use of strains of the parapox ovis virus against organ fibrosis |
| 01/17/2002 | WO2002004018A2 Mid-life vaccine and methods for boosting anti-mycobacterial immunity |
| 01/17/2002 | WO2002004017A2 Method for preparing oral vaccines |
| 01/17/2002 | WO2002004009A2 Method for treating cancer using an interleukin- 4 antagonist |
| 01/17/2002 | WO2002004007A2 Stable (fixed) forms of viral capsid proteins, fusion proteins and uses thereof |
| 01/17/2002 | WO2002004002A2 Use of strains of the parapox ovis virus for producing antiviral pharmaceuticals and anticancer pharmaceuticals |
| 01/17/2002 | WO2002003961A1 Microspheres and adjuvants for dna vaccine delivery |
| 01/17/2002 | WO2002003917A2 Alphavirus vectors and virosomes with modified hiv genes for use as vaccines |
| 01/17/2002 | WO2002003911A2 Prevention and treatment of alzheimer's disease |
| 01/17/2002 | WO2001079296B1 Humar emr2, a g-protein coupled receptor from the egf-tm7 family |
| 01/17/2002 | WO2001062786A3 Tlp peptides and dna sequences coding the same |